These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 37166370)

  • 41. Glioblastoma: therapeutic challenges, what lies ahead.
    Lima FR; Kahn SA; Soletti RC; Biasoli D; Alves T; da Fonseca AC; Garcia C; Romão L; Brito J; Holanda-Afonso R; Faria J; Borges H; Moura-Neto V
    Biochim Biophys Acta; 2012 Dec; 1826(2):338-49. PubMed ID: 22677165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spatial Heterogeneity of Invading Glioblastoma Cells Regulated by Paracrine Factors.
    Chonan Y; Yamashita T; Sampetrean O; Saya H; Sudo R
    Tissue Eng Part A; 2022 Jul; 28(13-14):573-585. PubMed ID: 34841881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.
    Thaci B; Brown CE; Binello E; Werbaneth K; Sampath P; Sengupta S
    Neuro Oncol; 2014 Oct; 16(10):1304-12. PubMed ID: 24723564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DHHC protein family targets different subsets of glioma stem cells in specific niches.
    Chen X; Hu L; Yang H; Ma H; Ye K; Zhao C; Zhao Z; Dai H; Wang H; Fang Z
    J Exp Clin Cancer Res; 2019 Jan; 38(1):25. PubMed ID: 30658672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.
    Caylioglu D; Meyer RJ; Hellmold D; Kubelt C; Synowitz M; Held-Feindt J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas.
    Ren Y; Huang Z; Zhou L; Xiao P; Song J; He P; Xie C; Zhou R; Li M; Dong X; Mao Q; You C; Xu J; Liu Y; Lan Z; Zhang T; Gan Q; Yang Y; Chen T; Huang B; Yang X; Xiao A; Ou Y; Su Z; Chen L; Zhang Y; Ju Y; Zhang Y; Wang Y
    Nat Commun; 2023 Feb; 14(1):1028. PubMed ID: 36823172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapy for glioblastoma: is it working?
    Zanders ED; Svensson F; Bailey DS
    Drug Discov Today; 2019 May; 24(5):1193-1201. PubMed ID: 30878561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting role of glioma stem cells for glioblastoma multiforme.
    Zhang X; Zhang W; Mao XG; Zhen HN; Cao WD; Hu SJ
    Curr Med Chem; 2013; 20(15):1974-84. PubMed ID: 23317162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular, histopathological, and genomic variants of glioblastoma.
    Karsy M; Huang T; Kleinman G; Karpel-Massler G
    Front Biosci (Landmark Ed); 2014 Jun; 19(7):1065-87. PubMed ID: 24896337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022.
    Gatto L; Franceschi E; Tosoni A; Di Nunno V; Bartolini S; Brandes AA
    Expert Opin Drug Discov; 2023 Mar; 18(3):269-286. PubMed ID: 36718723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective.
    Russo MN; Whaley LA; Norton ES; Zarco N; Guerrero-Cázares H
    Mol Aspects Med; 2023 Jun; 91():101167. PubMed ID: 36577547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.
    Pandey N; Anastasiadis P; Carney CP; Kanvinde PP; Woodworth GF; Winkles JA; Kim AJ
    Adv Drug Deliv Rev; 2022 Sep; 188():114415. PubMed ID: 35787387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The challenges associated with molecular targeted therapies for glioblastoma.
    Jue TR; McDonald KL
    J Neurooncol; 2016 May; 127(3):427-34. PubMed ID: 26900075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
    Pachocki CJ; Hol EM
    J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy.
    Mattei V; Santilli F; Martellucci S; Delle Monache S; Fabrizi J; Colapietro A; Angelucci A; Festuccia C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
    Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
    Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.